The Highwire with Del Bigtree - RATES OF MYOCARDITIS IN VAXXED YOUNG MALES HIGHER THAN THOUGHT

Episode Date: January 16, 2022

New data has just been released looking at myocarditis in young males after mRNA vaccination. Its findings should be alarming to anyone paying attention with specific focus on the shortcomings it has exposed in regards to the CDC’s significant undercounting of cases.#Myocarditis #JaxenReportBecome a supporter of this podcast: https://www.spreaker.com/podcast/the-highwire-with-del-bigtree--3620606/support.

We're talking about heart inflammation, myocarditis, pericarditis, and there is a gigantic study that just came out that was pretty much not reported in the mainstream whatsoever. And we're going to cover it here. This was out of Kaiser Permanente Northwest, one of the largest health care organizations in the United States. And its risk of mild pericaditis following COVID-19 MRI vaccination in a large integrated health system. They looked at people, a cohort from December 2020 to October 2021. And understand, this is what the conclusion was. They say, we identified additional valid cases of myo-parricarditis following an MRNA vaccination that would be missed by the VSD's search algorithm.

The VSD is a vaccine safety data link, which depends on select hospital discharge diagnosis codes. The true incidence of mild pericarditis is markedly higher than the incidents reported to U.S. advisory committees. So understand what these authors did. The VSD just looks at these ICD. codes. That's the code they use for billing. And that's all they do. And they say, well, that's what the code is and this is what we have. But these authors search the text, the actual text,

the doctors wrote down during the visit, search all of the information, all of those notes. And they also search the billing code. So sometimes someone, because the CDC only has certain centers that they surveil from. So if you get the shot in one of those centers and then your kid goes not to the center, but to a local doctor because his heart swells up, sometimes that gets lost in the billing codes and that doesn't get caught on the VSD. So these authors went and checked all of those things. And this is what they found. This is the image about the rates here, the chart. So you can see here the biggest number there, 537.1. If you track that down, males second dose per million. So that's 537.1 per million. So cases of 18. Yes, cases of myocarditis. Okay. Correct. Yes. And ages.

18 to 24 and the second biggest one is ages 12 to 17 and that's male second dose that's 377.4 per million now those numbers we're looking at those and thinking okay what's going on here what are they is the CDC really missing this well we pulled some reports from the cdc okay and this was a report this was their m mw our report from june and remember june 2021 this is when they had to pause because myocarditis became a big issue and they actually had to have a meeting. ASEP had to have a meeting on myocarditis to see if the benefits outweighed the risk. Well, let's look at the numbers they found here. They write in this report.

The highest reporting rates were among males, same age group parsing up, age 12 to 17 years, and those age 18 to 24 years. 62.8 and 50.5 reported myocarditis cases per million second doses of MRI, COVID vaccine administered respectively. So you're talking 62, basically 50, verse 537 per million and 377 per million. I think we brought up a graph. Let's see that graph so that people can see the comparison between what the CDC had said was the actual issue versus what is now being revised by this new study. So there you have it. The estimated by the CDC, remember, that's when they vote. They voted based on those numbers said, yeah, we're willing to accept 62.8 people per million and 50.5 per million. But what they're really accepting because they don't do decent data collection and didn't really care enough is that that number appears to be much high.

What is that? Five times higher at least, maybe, you know, 10 times higher, a thousand percent, a thousand percent increase to 37 per million in the 12 to 17 range and 18 to 24 in the 537 range. And by the way, people, this is Kaiser-Brenente. These are five. These are numbers of pro-vaccine people, pro-vaccine doctors just deciding to actually do a, decent investigation. So that is shocking. I mean, it's shocking how far off the CDC, which is who we trust, our government regulatory agency that is supposed to be blocking us from getting a dangerous product from the pharmaceutical industry that's bragging about making tens of billions of dollars

from it. And they don't even have their numbers straight and are way, way off the mark. Just to add a continued point to this, I pulled another slide here. This is from October 2021. So even further along the line and their numbers are basically still low we're still in the double digits here Pfizer's looking at 69.1 uh there with the second dose from ages 16 to 17 um 18 to 24 is 38.6 so it's just going lower and lower and lower so this is this is what we're looking at here from the latest from the CDC but let's go back to the FDA so they used Israeli data that's what they essentially base this entire booster emergency use authorization on. So how much data that they use? Where did they look at? Is it safe? Here's the actual slide from the presentation.

You can see here, they extended it in 12 to 15 year olds. So in males, remember males second dose is where that myocarditis is really getting hit hard. You can see here, zero post-dose three, that one, two, three, fourth column in males 12 to 15, zero. And if you go one more column over, there was only 3,178 kids that they used for that cohort, for that group of people that they were investigating. Now, let's go back to that Kaiser Permanente data. And that Kaiser Permanente data, if you break that down, you know, it's in per million. So that's kind of hard to understand what that really means.

But if you do the math on that, it's basically one in 100, 1,860 cases of myo credit. in males aged 18 to 24 and 1 in 2,000, 650. When we hear the millions, it's hard to wrap your head around it. But does anybody want to take a risk of a heart disease in your child in the thousands? One out of 1,800 cases that get the vaccine are going to have a heart issue. These aren't millions. This isn't hundreds of thousands of people. Folks, this is how close you are.

In a group of 1,800 kids, the chances is that one of them is going to have a heart condition. But go ahead. I'm sure that's not the point that you were. making but that is i think that is well in the realm of you know i always think like if i laid you know 1,800 cookies out at your average you know elementary school or high school that has them in kids and said one of these is going to poison you and give you a heart condition you go ahead and have a cookie the rest of you'd be fine don't think anyone's going to touch you know those cookies if it was one in a million cookies you might take the the roulette shot there right but one in

1,800 that's that is a super low and terrifying number And it is. And if you look at the Israeli data, we're looking at basically based this booster authorization for the third dose on 3,178 kids. So any epidemiologists out there, any scientists, any researcher worth their weight is, can you look at that and say that's a sufficiently powered study to figure out myocarditis rates? And that's real time data. That's not that's not data. That's a great point. It's one in 1,800. You don't even have enough for there to be potentially two cases you can. can see, right? And obviously, randomizing it, you would really need to see, you know, tens of thousands of kids at least so that you see that one in 800, one in 1,800 show up. They don't have enough people there to see two cases. And then if they even did see them, they say, well, it's, you know, it was not statistically significant because it was such a low number. We can't extrapolate from that. So it's just crappy. It's just continued total crap science and wishful thinking.